title: Nevirapine all set to succeed in Gauteng.
authors.forename: Chris
authors.initials: C
authors.lastname: Bateman
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D003376:Counseling / Q000458:organization & administration; D005260:Female; D015658:HIV Infections / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control* / Q000706:statistics & numerical data; D008427:Maternal Health Services / Q000458:organization & administration; D019829:Nevirapine / Q000627:therapeutic use*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000453:epidemiology / Q000517:prevention & control*; D011314:Preventive Health Services / Q000458:organization & administration; D012307:Risk Factors; D013019:South Africa / Q000453:epidemiology
chemical_list: D019380:Anti-HIV Agents; D019829:Nevirapine